Bolat Espembetov

Bolat Espembetov

PhD in Veterinary Science, Professor at the Research Institute for Biological Safety Problems

A specialist in biotechnology, alternative diagnostics for bacterial diseases in animals, vaccine and antimicrobial drug development, as well as in the creation of bacteriophages for food processing and production industries. Author of over 140 scientific works, including 25 articles published in journals recommended by the Committee for Quality Assurance in the Field of Education and Science of the Ministry of Education and Science of the Republic of Kazakhstan, 14 articles published in international peer-reviewed journals indexed by Scopus and with a non-zero impact factor according to Thomson Reuters, 28 patents for inventions, and 2 monographs. More than 20 conference abstracts have been published in the materials of national and international conferences.

For his contributions to science and education, he was awarded the Honorary Certificate of the Science Committee of the Ministry of Education and Science of Kazakhstan (2013), the Honorary Certificate of the Ministry of Education and Science (2017), and a regional medal for his contribution to regional development (awarded by the Akimat of Zhambyl Region, 2021).

In 2017, he received the “Leader of Science – 2017” diploma from JSC “National Center for Scientific and Technical Information” and a diploma from Clarivate Analytics for achievements in Russia and the CIS. Since 2020, he has been a member of the National Scientific Council on the priority direction “Sustainable Development of the Agro-Industrial Complex and Food Safety.” He has supervised two master’s students and is currently the scientific advisor for a PhD candidate. Hirsch index: Web of Science and Scopus – 6.0.

Key Achievements:

– Consortium of recombinant influenza A virus strains (FLU-NS1-124-L7/L12-H5N1, FLU-NS1-124-OMP16-H5N1, FLU-NS1-124-L7/L12-H1N1, FLU-NS1-124-OMP16-H1N1) of the ORTHOMYXOVIRIDAE family, INFLUENZAVIRUS genus, expressing brucellosis-specific immunodominant proteins for the development of a brucellosis vaccine;

– PCR-based test system for the diagnosis of Influenza B;

– Antigen for radial immunodiffusion used in diagnosing animal brucellosis;

– Antigen for a modified agglutination reaction used in diagnosing canine brucellosis;

– Attenuated strains of Pasteurella multocida bacteria for the production of prophylactic and diagnostic preparations;

– R-antigen for serodiagnosis of bovine brucellosis;

– R-serum for serodiagnosis of bovine brucellosis;

– Polyphage-based biopreparation for selective prophylactic disinfection of air and surfaces in medical, veterinary, residential, food production, and transportation settings;

– Developed the technology for producing an inactivated vaccine against epizootic lymphangitis in horses;

– Developed the technology for producing a biopreparation for treating glanders in horses.